These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16969347)

  • 1. Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells.
    Cellai I; Benvenuti S; Luciani P; Galli A; Ceni E; Simi L; Baglioni S; Muratori M; Ottanelli B; Serio M; Thiele CJ; Peri A
    Br J Cancer; 2006 Oct; 95(7):879-88. PubMed ID: 16969347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo effects of rosiglitazone in a human neuroblastoma xenograft.
    Cellai I; Petrangolini G; Tortoreto M; Pratesi G; Luciani P; Deledda C; Benvenuti S; Ricordati C; Gelmini S; Ceni E; Galli A; Balzi M; Faraoni P; Serio M; Peri A
    Br J Cancer; 2010 Feb; 102(4):685-92. PubMed ID: 20068562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression.
    Cao LQ; Shao ZL; Liang HH; Zhang DW; Yang XW; Jiang XF; Xue P
    Cancer Lett; 2015 Apr; 359(1):127-35. PubMed ID: 25592041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
    Magenta G; Borenstein X; Rolando R; Jasnis MA
    BMC Cancer; 2008 Feb; 8():47. PubMed ID: 18261208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligands for the peroxisome proliferator-activated receptor-gamma have inhibitory effects on growth of human neuroblastoma cells in vitro.
    Valentiner U; Carlsson M; Erttmann R; Hildebrandt H; Schumacher U
    Toxicology; 2005 Sep; 213(1-2):157-68. PubMed ID: 16009482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
    Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
    J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the PPAR-gamma agonist rosiglitazone on neuroblastoma SK-N-SH cells in a metastatic xenograft mouse model.
    Krieger-Hinck N; Schumacher U; Müller A; Valentiner U
    Oncol Res; 2010; 18(8):387-93. PubMed ID: 20441053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism.
    Lützen U; Zhao Y; Lucht K; Zuhayra M; Marx M; Cascorbi I; Culman J
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):37-48. PubMed ID: 27664035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone activation of PPARγ-dependent signaling is neuroprotective in mutant huntingtin expressing cells.
    Chiang MC; Cheng YC; Nicol CJ; Lin KH; Yen CH; Chen SJ; Huang RN
    Exp Cell Res; 2015 Nov; 338(2):183-93. PubMed ID: 26362846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-γ inhibits pancreatic cancer cell invasion and metastasis via regulating MMP-2 expression through PTEN.
    Li Y; Zhang DW; Lin DQ; Cao LQ
    Mol Med Rep; 2015 Oct; 12(4):6255-60. PubMed ID: 26299428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
    Winczyk K; Kunert-Radek J; Gruszka A; Radek M; Ławnicka H; Pawlikowski M
    Neuro Endocrinol Lett; 2009 Mar; 30(1):107-10. PubMed ID: 19300395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma cells undergo differentiation upon exposure to rosiglitazone and all-trans retinoic acid.
    Huang H; Wu D; Fu J; Chen G
    Leuk Lymphoma; 2009 Jun; 50(6):966-73. PubMed ID: 19373597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone protects neuroblastoma cells against advanced glycation end products-induced injury.
    Wang L; Yu CJ; Liu W; Cheng LY; Zhang YN
    Acta Pharmacol Sin; 2011 Aug; 32(8):991-8. PubMed ID: 21765445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.
    Mansour M; Schwartz D; Judd R; Akingbemi B; Braden T; Morrison E; Dennis J; Bartol F; Hazi A; Napier I; Abdel-Mageed AB
    Int J Oncol; 2011 Feb; 38(2):537-46. PubMed ID: 21170507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
    Sommer M; Wolf G
    Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R.
    Ferruzzi P; Ceni E; Tarocchi M; Grappone C; Milani S; Galli A; Fiorelli G; Serio M; Mannelli M
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1332-9. PubMed ID: 15585569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis.
    Fuenzalida K; Quintanilla R; Ramos P; Piderit D; Fuentealba RA; Martinez G; Inestrosa NC; Bronfman M
    J Biol Chem; 2007 Dec; 282(51):37006-15. PubMed ID: 17965419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-proliferative effect of rosiglitazone in the human T-lymphocyte leukaemia cell line Jurkat cells.
    Wei R; Yu F; Yang J; Gao H; Wang H; Hong T
    Cell Biol Int; 2018 May; 42(5):515-524. PubMed ID: 29274299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells.
    Crosswell HE; Dasgupta A; Alvarado CS; Watt T; Christensen JG; De P; Durden DL; Findley HW
    BMC Cancer; 2009 Nov; 9():411. PubMed ID: 19939254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.